Harvard Apparatus Regenerative Technology, Inc. earnings releases HRGN

Annual Quarterly

Harvard Apparatus Regenerative Technology, Inc. last reported quarterly results on Nov 14, 2022, for the quarter ended Sep 30, 2022. It usually reports 1–46 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 1–46 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Nov 14, 2022 45 days after quarter end	— ended Sep 30, 2022	—	—	—
Aug 4, 2022 35 days after quarter end	— ended Jun 30, 2022	—	—	—
Apr 1, 2022 1 days after quarter end	— ended Mar 31, 2022	—	—	—
Nov 15, 2021 46 days after quarter end	— ended Sep 30, 2021	—	—	—
Aug 13, 2021 44 days after quarter end	— ended Jun 30, 2021	—	—	—
Apr 13, 2021 13 days after quarter end	— ended Mar 31, 2021	—	—	—
Nov 13, 2020 44 days after quarter end	— ended Sep 30, 2020	—	—	—
Aug 13, 2020 44 days after quarter end	— ended Jun 30, 2020	—	—	—

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: HRGN (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Holliston, MA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1563665
Former names: Biostage, Inc. (until Jul 10, 2023)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.